The Michael Savage endorsement of Leronlimab trumps (no pun intended) any of RLFTFs connections, IMO. He is personally close to and has access to Trump and many in his inner circle.
There's also Chris Christie who's been admitted to a hospital running the CD12 trial and rumor has it he specifically chose the hospital because they have access to leronlimab. Again, just a rumor brewing on Ihub and Twitter, but sounds reasonable to me.
There are multiple senators and WH personnel infected at this time and that number is sure to rise in the coming days. I hate to look at it this way, but I foresee multiple shots on goal for Leronlimab, especially if the S/C interim analysis is announced this week. This treatment can prevent complications and save lives.
This is why I mentioned media coverage last night. Certainly not a commercial and not necessarily involving Nader or anyone live on air. An effective PR person has connections and access to media outlets and reporters and certainly right now, COVID treatments IN TRIALS are on topic, especially after Trump's speech today.
As was mentioned, now is the time to strike while the iron is hot. It's not about bumping up share price, it's all about bumping up name recognition for leronlimab to coincide with current events and the impending CD12 interim readout.
There's also Chris Christie who's been admitted to a hospital running the CD12 trial and rumor has it he specifically chose the hospital because they have access to leronlimab. Again, just a rumor brewing on Ihub and Twitter, but sounds reasonable to me.
There are multiple senators and WH personnel infected at this time and that number is sure to rise in the coming days. I hate to look at it this way, but I foresee multiple shots on goal for Leronlimab, especially if the S/C interim analysis is announced this week. This treatment can prevent complications and save lives.
This is why I mentioned media coverage last night. Certainly not a commercial and not necessarily involving Nader or anyone live on air. An effective PR person has connections and access to media outlets and reporters and certainly right now, COVID treatments IN TRIALS are on topic, especially after Trump's speech today.
As was mentioned, now is the time to strike while the iron is hot. It's not about bumping up share price, it's all about bumping up name recognition for leronlimab to coincide with current events and the impending CD12 interim readout.
14
